Dilation
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Efficacy of the MydCombi on Pupillary Dilation in Pediatric and Adult Patients (NCT06366217) | University of California, San Francisco | 2024-09-30 |
| Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects (NCT05223478) | Ocuphire Pharma, Inc. | 2021-12-17 |
| Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3) (NCT05134974) | Ocuphire Pharma, Inc. | 2021-11-18 |
| Efficacy of the Nanodropper Device on Pupillary Dilation (NCT05274321) | University of California, San Francisco | 2021-07-29 |
| Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (NCT04620213) | Ocuphire Pharma, Inc. | 2020-11-18 |
| Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis (NCT04024891) | Ocuphire Pharma, Inc. | 2019-08-13 |
Track Dilation automatically
Every clearance here is in the API, with alerts when new ones post.